###begin article-title 0
###xml 0 23 0 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cryptococcus neoformans</italic>
###xml 0 12 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 0 23 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
Cryptococcus neoformans Is Resistant to Surfactant Protein A Mediated Host Defense Mechanisms
###end article-title 0
###begin p 1
Conceived and designed the experiments: SG. Performed the experiments: SG AZ. Analyzed the data: JP JW MR. Wrote the paper: SG. Other: Edited the paper: JP JW.
###end p 1
###begin p 2
###xml 81 104 81 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cryptococcus neoformans</italic>
###xml 192 205 192 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 555 568 555 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 665 678 665 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 686 694 686 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 790 803 790 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 842 855 842 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 1044 1057 1044 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 1195 1208 1195 1208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 1323 1330 1323 1330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1364 1371 1364 1371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SP-A-/-</italic>
###xml 1667 1680 1663 1676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 1709 1716 1705 1712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SP-A-/-</italic>
###xml 1875 1888 1871 1884 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 81 93 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 81 104 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
###xml 192 205 <span type="species:ncbi:5207">C. neoformans</span>
###xml 206 211 <span type="species:ncbi:4932">yeast</span>
###xml 555 568 <span type="species:ncbi:5207">C. neoformans</span>
###xml 665 678 <span type="species:ncbi:5207">C. neoformans</span>
###xml 790 803 <span type="species:ncbi:5207">C. neoformans</span>
###xml 805 808 <span type="species:ncbi:5207">H99</span>
###xml 842 855 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1044 1057 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1195 1208 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1358 1362 <span type="species:ncbi:10090">mice</span>
###xml 1387 1391 <span type="species:ncbi:10090">mice</span>
###xml 1667 1680 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1731 1735 <span type="species:ncbi:10090">mice</span>
###xml 1875 1888 <span type="species:ncbi:5207">C. neoformans</span>
Initiation of a protective immune response to infection by the pathogenic fungus Cryptococcus neoformans is mediated in part by host factors that promote interactions between immune cells and C. neoformans yeast. Surfactant protein A (SP-A) contributes positively to pulmonary host defenses against a variety of bacteria, viruses, and fungi in part by promoting the recognition and phagocytosis of these pathogens by alveolar macrophages. In the present study we investigated the role of SP-A as a mediator of host defense against the pulmonary pathogen, C. neoformans. Previous studies have shown that SP-A binds to acapsular and minimally encapsulated strains of C. neoformans. Using in vitro binding assays we confirmed that SP-A does not directly bind to a fully encapsulated strain of C. neoformans (H99). However, we observed that when C. neoformans was incubated in bronchoalveolar fluid, SP-A binding was detected, suggesting that another alveolar host factor may enable SP-A binding. Indeed, we discovered that SP-A binds encapsulated C. neoformans via a previously unknown IgG dependent mechanism. The consequence of this interaction was the inhibition of IgG-mediated phagocytosis of C. neoformans by alveolar macrophages. Therefore, to assess the contribution of SP-A to the pulmonary host defenses we compared in vivo infections using SP-A null mice (SP-A-/-) and wild-type mice in an intranasal infection model. We found that the immune response assessed by cellular counts, TNFalpha cytokine production, and fungal burden in lungs and bronchoalveolar lavage fluids during early stages of infection were equivalent. Furthermore, the survival outcome of C. neoformans infection was equivalent in SP-A-/- and wild-type mice. Our results suggest that unlike a variety of bacteria, viruses, and other fungi, progression of disease with an inhalational challenge of C. neoformans does not appear to be negatively or positively affected by SP-A mediated mechanisms of pulmonary host defense.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 0 23 0 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cryptococcus neoformans</italic>
###xml 225 238 225 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 426 439 426 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 620 623 620 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Mitchell1">[1]</xref>
###xml 908 921 908 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 965 978 965 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 0 12 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 0 23 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
###xml 164 170 <span type="species:ncbi:9606">humans</span>
###xml 225 238 <span type="species:ncbi:5207">C. neoformans</span>
###xml 371 377 <span type="species:ncbi:4932">yeasts</span>
###xml 426 439 <span type="species:ncbi:5207">C. neoformans</span>
###xml 908 921 <span type="species:ncbi:5207">C. neoformans</span>
###xml 965 978 <span type="species:ncbi:5207">C. neoformans</span>
Cryptococcus neoformans is an environmentally ubiquitous fungal pathogen that is responsible for significant morbidity and mortality in immunocompromised hosts. In humans, a pulmonary infection occurs following inhalation of C. neoformans cells. The identity of the infectious propagule remains unknown but is presumed to be either small, poorly encapsulated, desiccated yeasts or basidiospores. Hematogenous dissemination of C. neoformans from the lungs to the central nervous system can result in cryptococcal meningoencephalitis, a life-threatening complication that requires aggressive chemotherapeutic intervention [1]. In healthy hosts, initiation of an innate and adaptive cellular immune response limits the severity of the infection to an asymptomatic and often self-resolving pulmonary infection in most cases. The identification of those host factors that contribute to effective defenses against C. neoformans will not only broaden our understanding of C. neoformans pathogenesis but may aide in the development of therapeutic strategies for the prevention and treatment of this important fungal disease.
###end p 4
###begin p 5
###xml 194 216 194 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 216 219 216 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Tino1">[2]</xref>
###xml 221 245 221 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 245 248 245 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Tino1">[2]</xref>
###xml 250 277 250 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Respiratory Syncytial Virus</italic>
###xml 277 280 277 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Ghildyal1">[3]</xref>
###xml 282 293 282 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Influenza A</italic>
###xml 300 303 300 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Hartshorn1">[4]</xref>
###xml 319 340 319 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aspergillus fumigatus</italic>
###xml 340 343 340 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Madan1">[5]</xref>
###xml 348 369 348 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pneumocystis jiroveci</italic>
###xml 369 372 369 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-McCormack1">[6]</xref>
###xml 663 666 663 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Crouch1">[7]</xref>
###xml 667 670 667 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Wright2">[9]</xref>
###xml 681 689 681 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 779 792 779 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 828 832 828 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Schelenz1">[10]</xref>
###xml 834 838 834 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Walenkamp1">[11]</xref>
###xml 882 895 882 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 194 216 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
###xml 221 245 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 282 299 <span type="species:ncbi:11320">Influenza A virus</span>
###xml 319 340 <span type="species:ncbi:5085">Aspergillus fumigatus</span>
###xml 348 369 <span type="species:ncbi:42068">Pneumocystis jiroveci</span>
###xml 779 792 <span type="species:ncbi:5207">C. neoformans</span>
###xml 822 827 <span type="species:ncbi:4932">yeast</span>
###xml 882 895 <span type="species:ncbi:5207">C. neoformans</span>
Surfactant protein A (SP-A) is one such innate host factor that has been shown to contribute positively to the pulmonary defenses against a diverse group of pathogenic microorganisms including, Pseudomonas aeruginosa[2], Streptococcus pneumoniae[2], Respiratory Syncytial Virus[3], Influenza A virus [4], and the fungi Aspergillus fumigatus[5] and Pneumocystis jiroveci[6]. SP-A mediates host defense via direct interactions between the carbohydrate recognition domain of SP-A and microbial ligands, which results in the opsonization and phagocytosis of pathogenic microorganisms by alveolar macrophages, and indirectly via modulation of the host immune response [7]-[9]. Previous in vitro studies have shown that SP-A can bind to acapsular and minimally encapsulated strains of C. neoformans but not heavily-encapsulated yeast [10], [11]. The role of SP-A in host defenses against C. neoformans remains to be fully elucidated.
###end p 5
###begin p 6
###xml 118 131 118 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 138 141 138 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Mitchell1">[1]</xref>
###xml 250 263 250 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 464 477 464 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 749 762 749 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 776 784 776 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 849 862 849 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 944 957 944 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 959 966 959 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SP-A-/-</italic>
###xml 1098 1111 1098 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 1219 1232 1219 1232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 118 131 <span type="species:ncbi:5207">C. neoformans</span>
###xml 133 136 <span type="species:ncbi:5207">H99</span>
###xml 250 263 <span type="species:ncbi:5207">C. neoformans</span>
###xml 434 439 <span type="species:ncbi:4932">yeast</span>
###xml 464 477 <span type="species:ncbi:5207">C. neoformans</span>
###xml 749 762 <span type="species:ncbi:5207">C. neoformans</span>
###xml 764 767 <span type="species:ncbi:5207">H99</span>
###xml 849 862 <span type="species:ncbi:5207">C. neoformans</span>
###xml 944 957 <span type="species:ncbi:5207">C. neoformans</span>
###xml 967 971 <span type="species:ncbi:10090">mice</span>
###xml 978 984 <span type="species:ncbi:10090">murine</span>
###xml 1098 1111 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1219 1232 <span type="species:ncbi:5207">C. neoformans</span>
In the present study we investigated the effect of SP-A on host defense against an encapsulated, pathogenic strain of C. neoformans (H99) [1]. The rationale for studying an encapsulated fully virulent strain was two-fold. First, acapsular strains of C. neoformans are uniformly avirulent, not clinically relevant and thus would not be suitable for investigating the role of SP-A as a mediator of host defense. Second, if a desiccated yeast form or basidiospore of C. neoformans were inhaled, rapid rehydration of capsule occurs in airway structures and the capsular structure is expected to be a major factor in the initial host-pathogen pulmonary interaction. We, therefore, initiated our study by first investigating the direct binding of SP-A to C. neoformans (H99). Using in vitro binding assays we confirmed that SP-A does not directly bind to C. neoformans but, we did discover an IgG dependent mechanism that does enable SP-A binding to C. neoformans. SP-A-/- mice and a murine cryptococcosis inhalation infection model were then used to investigate the role of SP-A in host defense against C. neoformans. These experiments revealed that SP-A does not appear to contribute to the pulmonary host defenses against C. neoformans.
###end p 6
###begin title 7
Materials and Methods
###end title 7
###begin title 8
Strains and media
###end title 8
###begin p 9
###xml 0 23 0 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cryptococcus neoformans</italic>
###xml 29 35 29 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">grubii</italic>
###xml 567 580 549 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 0 12 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 0 23 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
###xml 44 47 <span type="species:ncbi:5207">H99</span>
###xml 140 143 <span type="species:ncbi:5207">H99</span>
###xml 162 167 <span type="species:ncbi:4932">yeast</span>
###xml 202 207 <span type="species:ncbi:4932">yeast</span>
###xml 303 308 <span type="species:ncbi:4932">yeast</span>
###xml 567 580 <span type="species:ncbi:5207">C. neoformans</span>
###xml 712 717 <span type="species:ncbi:4932">yeast</span>
Cryptococcus neoformans var. grubii strains H99 (serotype A, mating type alpha) was revived from 15% glycerol stocks stored at -80degreesC. H99 was maintained on yeast extract peptone dextrose (YPD; 1% yeast extract, 2% peptone and 2% dextrose) agar plates at 30degreesC. Prior to use in these studies, yeast were grown in YPD liquid medium overnight at 30degreesC, harvested, washed three times with sterile phosphate-buffered saline (PBS), suspended in phagocytosis buffer and counted with a hemacytometer to determine cell concentrations. For phagocytosis assays, C. neoformans were labeled with Alexa Fluor 647 (Invitrogen, Carlsbad, CA) per the manufacturers instructions. Stocks of Alexa Fluor 647 labeled yeast were maintained at -20degreesC until needed.
###end p 9
###begin title 10
Purification and Alexa Fluor 488 labeling of surfactant protein A
###end title 10
###begin p 11
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Alcorn1">[12]</xref>
###xml 547 551 547 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Alcorn1">[12]</xref>
###xml 626 643 626 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Limulus amebocyte</italic>
###xml 64 72 <span type="species:ncbi:9606">patients</span>
SP-A was isolated from the lavage fluid of alveolar proteinosis patients as previously described [12]. Briefly, the surfactant pellet from the lavage fluid was extracted with butanol. Butanol insoluble proteins were then resuspended in octylglucopyranoside (OGP) in 0.15 M NaCl. SP-A, which is insoluble in OGP and salt, was then suspended in Tris-buffered water, pH 7.4. Remaining OGP was removed by dialysis against 5 mM Tris-buffered water, pH 7.4. SP-A was then treated with polymyxin agarose beads to remove endotoxin as previously described [12]. All SP-A preparations were assayed for endotoxin contamination using the Limulus amebocyte lysate assay (BioWhittaker, Rockland, ME) per the manufacturer's instructions. SP-A was labeled with Alexa Fluor 488 (Invitrogen, Carlsbad, CA) per the manufactures instructions. The ratio of moles dye per mole of protein was quantified and SP-A preparations with labeling efficiencies between 4 and 10 were used for binding assays.
###end p 11
###begin title 12
Surfactant protein A binding assays
###end title 12
###begin p 13
###xml 26 39 26 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 393 394 375 376 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 771 784 753 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 864 886 846 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli HB101</italic>
###xml 26 39 <span type="species:ncbi:5207">C. neoformans</span>
###xml 41 46 <span type="species:ncbi:4932">yeast</span>
###xml 295 300 <span type="species:ncbi:4932">yeast</span>
###xml 468 473 <span type="species:ncbi:9606">Human</span>
###xml 771 784 <span type="species:ncbi:5207">C. neoformans</span>
###xml 864 886 <span type="species:ncbi:634468">Escherichia coli HB101</span>
To assess SP-A binding to C. neoformans, yeast were treated with Alexa Fluor 488 labeled SP-A (5 to 20 microg/ml), anti-GXM IgG mAb 18B7 (1.0 microg/ml, generous gift of Arturo Casadevall) or a combination of SP-A and anti-GXM IgG for 60 minutes at 37degreesC with shaking. Following treatment, yeast were washed twice with 5 volumes of phagocytosis buffer (PB) (PBS +0.1% BSA +900 microM CaCl2) and binding was quantified by flow cytometric analysis (Duke University Human Vaccine Institute Flow Cytometry Core Facility, Durham, NC). Data analysis was performed using the FlowJo software package (Ver. 6.3.3, Tree Star, Inc., Ashland, OR). For fluorescence microscopy experiments, PE-Texas Red (Invitrogen, Carlsbad, CA) labeled anti-GXM IgG mAb 18B7 was used to detect C. neoformans capsule. Calcofluor was used to stain the cell wall. SP-A binding assays using Escherichia coli HB101 were used to validate the binding activity of all SP-A preparations used in this study. Binding was visualized by fluorescent microscopy (Zeiss Axioskop 2 Plus microscope). Fluorescent images were captured using an AxioCam MRm (Carl Zeiss, Thornwood, NY) digital camera and AxioVision 4.5 software (Carl Zeiss, Thornwood, NY). Images were uniformly processed to adjust contrast and image clarity using Adobe Photoshop CS2.
###end p 13
###begin title 14
Uptake and binding assays
###end title 14
###begin p 15
###xml 297 310 297 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 40 59 <span type="species:ncbi:10116">Sprague-Dawley rats</span>
###xml 297 310 <span type="species:ncbi:5207">C. neoformans</span>
###xml 336 341 <span type="species:ncbi:4932">yeast</span>
###xml 502 507 <span type="species:ncbi:4932">Yeast</span>
###xml 634 639 <span type="species:ncbi:4932">Yeast</span>
Alveolar macrophages were isolated from Sprague-Dawley rats (Taconic, Germantown, NY). Bronchoalveolar lavage (BAL) was performed with 10 ml of PBS containing 0.2 mM EGTA (instilled 10 times). Cells were washed once with PBS and resuspended in PB. Prior to the addition of Alexa Fluor 647 labeled C. neoformans to alveolar macrophages, yeast were incubated with SP-A (5 to 20 microg/ml), anti-GXM IgG (1.0 microg/ml) or a combination of SP-A and anti-GXM IgG at 37degreesC for 60 minutes with shaking. Yeast were washed twice with 5 volumes of PB and added to alveolar macrophages in suspension at a multiplicity of infection of 1:1. Yeast and alveolar macrophages were co-incubated for 60 minutes at 37degreesC with gentle shaking and attachment/phagocytosis was quantified by flow cytometric analysis.
###end p 15
###begin title 16
In vivo testing
###end title 16
###begin p 17
###xml 0 13 0 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 96 103 96 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SP-A-/-</italic>
###xml 125 138 125 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 176 189 176 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 245 252 245 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SP-A-/-</italic>
###xml 314 315 314 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 323 324 323 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 396 400 392 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Giles1">[13]</xref>
###xml 430 431 426 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 570 583 566 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 585 592 581 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SP-A-/-</italic>
###xml 650 651 646 647 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1023 1036 1019 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 1434 1441 1426 1433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SP-A-/-</italic>
###xml 1522 1523 1514 1515 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1595 1599 1583 1587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Giles1">[13]</xref>
###xml 1600 1604 1588 1592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Giles3">[15]</xref>
###xml 0 13 <span type="species:ncbi:5207">C. neoformans</span>
###xml 31 34 <span type="species:ncbi:5207">H99</span>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
###xml 125 138 <span type="species:ncbi:5207">C. neoformans</span>
###xml 176 189 <span type="species:ncbi:5207">C. neoformans</span>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
###xml 432 437 <span type="species:ncbi:4932">yeast</span>
###xml 570 583 <span type="species:ncbi:5207">C. neoformans</span>
###xml 607 611 <span type="species:ncbi:10090">mice</span>
###xml 652 657 <span type="species:ncbi:4932">yeast</span>
###xml 1023 1036 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1038 1043 <span type="species:ncbi:10090">Mouse</span>
###xml 1254 1258 <span type="species:ncbi:10090">mice</span>
###xml 1463 1467 <span type="species:ncbi:10090">mice</span>
###xml 1606 1610 <span type="species:ncbi:10090">Mice</span>
###xml 1711 1715 <span type="species:ncbi:10090">Mice</span>
C. neoformans wild-type strain H99 was used to assess the immune response and susceptibility of SP-A-/- mice to infection by C. neoformans. The immune response to infection by C. neoformans was assessed by infecting groups consisting of 5 or 10 SP-A-/- or wild-type C57BL/6 mice via intranasal inhalation with 1x104 or 1x105 CFU of each strain (in a volume of 50 microl), as described previously [13]. The rationale for using 1x104 yeast for studies that assessed the host immune response was so that we could measure the immune response to a relatively small number of C. neoformans. SP-A-/- and wild-type mice were infected with an inoculum of 1x105 yeast, which is a common inoculum size used for susceptibility studies. Bronchoalveolar lavages (1 ml sterile PBS instilled times 3; recovery 0.8-0.9 ml) were performed and total lung tissues were collected for colony forming unit determination at days three and seven post-infection. These time points were chosen so as to capture early events in the immune response to C. neoformans. Mouse TNFalpha ELISAs (R&D Systems) were performed on bronchoalveolar lavage fluid per the manufacture's instruction. Cell differentials were performed by microscopic examination of cytospin preparations of BAL from mice seven days post infection. Slides were prepared with Wright-Giemsa stain per the manufacturers instructions. Susceptibility studies were performed with groups consisting of 5 SP-A-/- or wild-type C57BL/6 mice that were infected via intranasal inhalation with 1x105 CFU of each strain (in a volume of 50 microl), as described previously [13]-[15]. Mice that appeared moribund (i.e. lethargic or exhibiting rapid weight loss) or in pain were euthanized. Mice were monitored twice daily and the mean time to mortality between the groups was determined. The Duke University Institutional Animal Use and Care Committee approved the animal protocol used for these experiments.
###end p 17
###begin title 18
Statistics
###end title 18
###begin p 19
###xml 306 307 306 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 256 261 <span type="species:ncbi:10090">mouse</span>
Statistical analysis was performed using the JMP statistics package (SAS, Cary, NC). Student's T-test or ANOVA was used to assess binding, phagocytosis and cell differential data for statistical significance. Survival statistics were performed to evaluate mouse survival data for statistical significance. P-values<0.05 were considered statistically significant.
###end p 19
###begin title 20
Results
###end title 20
###begin title 21
###xml 35 48 35 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 35 48 <span type="species:ncbi:5207">C. neoformans</span>
Antibody dependent SP-A binding to C. neoformans
###end title 21
###begin p 22
###xml 69 77 69 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 157 170 157 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 170 174 170 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Schelenz1">[10]</xref>
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Walenkamp1">[11]</xref>
###xml 291 304 291 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 316 317 316 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 346 368 346 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli HB101</italic>
###xml 574 587 574 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 596 605 596 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001370-g001">Figure 1A</xref>
###xml 657 670 657 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 683 684 683 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 873 882 873 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001370-g001">Figure 1B</xref>
###xml 993 1006 993 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 1088 1101 1088 1101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 157 170 <span type="species:ncbi:5207">C. neoformans</span>
###xml 291 304 <span type="species:ncbi:5207">C. neoformans</span>
###xml 305 310 <span type="species:ncbi:4932">yeast</span>
###xml 346 368 <span type="species:ncbi:634468">Escherichia coli HB101</span>
###xml 570 573 <span type="species:ncbi:5207">H99</span>
###xml 574 587 <span type="species:ncbi:5207">C. neoformans</span>
###xml 588 594 <span type="species:ncbi:4932">yeasts</span>
###xml 657 670 <span type="species:ncbi:5207">C. neoformans</span>
###xml 671 677 <span type="species:ncbi:4932">yeasts</span>
###xml 993 1006 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1088 1101 <span type="species:ncbi:5207">C. neoformans</span>
Previous studies by Walenkamp et al. and Schelenz et al. showed that in vitro, SP-A binding is restricted to acapsular and minimally encapsulated strains of C. neoformans[10], [11]. To confirm these results, we performed flow cytometry to quantify AF488 labeled SP-A binding to encapsulated C. neoformans yeast (1x105). SP-A binding assays using Escherichia coli HB101 were performed to confirm the binding activity of all SP-A preparations (results not shown). Our results were consistent with those of previous studies; we did not observe SP-A binding to encapsulated H99 C. neoformans yeasts (Figure 1A). To extend this observation to biological fluids, C. neoformans yeasts (1x105) were next treated with undiluted bronchoalveolar lavage fluid (BAL). In contrast to the previous conditions, we were able to detect a small amount of SP-A binding under these conditions (Figure 1B). Our interpretation of these results was that another factor present in BAL may have enabled SP-A to bind to C. neoformans. In the process of considering factors in BAL that might mediate SP-A binding to C. neoformans, immunoglobulins were selected as candidates for binding assays.
###end p 22
###begin title 23
###xml 44 57 44 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 44 57 <span type="species:ncbi:5207">C. neoformans</span>
###xml 58 63 <span type="species:ncbi:4932">yeast</span>
SP-A does not directly bind to encapsulated C. neoformans yeast.
###end title 23
###begin p 24
###xml 5 18 5 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 24 25 24 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 239 252 229 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 258 259 248 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 5 18 <span type="species:ncbi:5207">C. neoformans</span>
###xml 239 252 <span type="species:ncbi:5207">C. neoformans</span>
(A.) C. neoformans (1x105) were treated with Alexa Flour 488 labeled SP-A (20 microg/ml) for 60 minutes at 37degreesC. Surfactant protein binding was quantified by flow cytometric analysis. SP-A binding was not detected. (B.) In contrast, C. neoformans (1x105) treated with undiluted BAL exhibited a small amount of SP-A binding. Results are one representative experiment of at least three (A.) or two (B.) experiments performed.
###end p 24
###begin p 25
###xml 188 201 188 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 279 283 279 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Zaragoza1">[16]</xref>
###xml 376 389 376 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 391 404 391 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 616 629 612 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 637 646 633 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001370-g002">Figure 2A</xref>
###xml 842 851 838 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001370-g002">Figure 2A</xref>
###xml 1080 1093 1072 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 1137 1146 1129 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001370-g002">Figure 2B</xref>
###xml 1331 1344 1323 1336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 1434 1443 1426 1435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001370-g002">Figure 2B</xref>
###xml 1525 1538 1517 1530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 188 201 <span type="species:ncbi:5207">C. neoformans</span>
###xml 376 389 <span type="species:ncbi:5207">C. neoformans</span>
###xml 391 404 <span type="species:ncbi:5207">C. neoformans</span>
###xml 616 629 <span type="species:ncbi:5207">C. neoformans</span>
###xml 951 956 <span type="species:ncbi:4932">yeast</span>
###xml 1080 1093 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1331 1344 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1525 1538 <span type="species:ncbi:5207">C. neoformans</span>
Several studies have reported that naturally occurring IgG antibodies can non-specifically bind to pathogenic fungi. In addition, antibody binding can alter the physical properties of the C. neoformans capsule and affect the ability of other opsonins, such as complement to bind [16]. Therefore, we investigated whether IgG antibody binding to capsule enabled SP-A binding to C. neoformans. C. neoformans cells were opsonized with anti-GXM IgG and then treated with AF488 labeled SP-A (20 microg/ml) or left untreated as a control. Calcofluor was used to visualize the cell wall. While SP-A did not bind directly to C. neoformans cells (Figure 2A), the addition of anti-GXM IgG to the interaction resulted in robust SP-A binding that appeared to co-localize with anti-GXM IgG binding and was generally uniform throughout the capsular matrix (Figure 2A). Due to the size of the capsule, some areas bound by SP-A and anti-GXM IgG appear larger than the yeast. Further analysis by flow cytometry demonstrated that SP-A binding (1, 10, 20, and 40 microg/ml) to anti-GXM IgG opsonized C. neoformans cells occurred in a dose-dependent manner (Figure 2B). The carbohydrate recognition domain of SP-A is known to bind sugars in a calcium dependent manner. We observed that EDTA (1 mM) did not affect SP-A binding to anti-GXM IgG opsonized C. neoformans, suggesting that the carbohydrate recognition domain was not involved in this mechanism (Figure 2B). Furthermore, this result suggested that SP-A binding to anti-GXM IgG opsonized C. neoformans is not due to antibody mediated exposure of carbohydrate ligands.
###end p 25
###begin title 26
###xml 14 27 14 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 14 27 <span type="species:ncbi:5207">C. neoformans</span>
SP-A can bind C. neoformans via an IgG dependent mechanism.
###end title 26
###begin p 27
###xml 5 18 5 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 30 31 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 333 346 333 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 420 433 416 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 5 18 <span type="species:ncbi:5207">C. neoformans</span>
###xml 19 24 <span type="species:ncbi:4932">yeast</span>
###xml 333 346 <span type="species:ncbi:5207">C. neoformans</span>
###xml 420 433 <span type="species:ncbi:5207">C. neoformans</span>
(A.) C. neoformans yeast (1x105) were treated with AF488 labeled SP-A (Panel A), PE-Texas Red labeled anti-GXM IgG (Panel B) and PE-Texas Red labeled anti-GXM IgG and AF488 labeled SP-A (Panel C). Calcofluor was added to all samples to visualize the cell wall. SP-A binding to IgG opsonized (Panel C) but not non-opsonized (Panel A) C. neoformans was observed. Scale bar length is equal to 10 microm. (B.) IgG opsonized C. neoformans were treated with SP-A concentrations of 1, 10, 20, 40 microg/ml and binding was quantified by flow cytometric analysis. EDTA (1 mM) was included to determine if SP-A binding required the carbohydrate recognition domain. Histograms represent the mean fluorescence intensity of the AF 488 channel. At least 10,000 particles were interrogated for each sample.
###end p 27
###begin title 28
###xml 44 57 44 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 44 57 <span type="species:ncbi:5207">C. neoformans</span>
SP-A inhibits IgG dependent phagocytosis of C. neoformans by alveolar macrophages
###end title 28
###begin p 29
###xml 97 110 97 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 135 143 135 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 167 180 167 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 250 263 250 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 419 432 419 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 640 648 628 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001370-g003">Figure 3</xref>
###xml 744 745 728 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 800 813 784 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 957 965 935 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001370-g003">Figure 3</xref>
###xml 97 110 <span type="species:ncbi:5207">C. neoformans</span>
###xml 167 180 <span type="species:ncbi:5207">C. neoformans</span>
###xml 250 263 <span type="species:ncbi:5207">C. neoformans</span>
###xml 419 432 <span type="species:ncbi:5207">C. neoformans</span>
###xml 800 813 <span type="species:ncbi:5207">C. neoformans</span>
###xml 814 819 <span type="species:ncbi:4932">yeast</span>
We next investigated whether SP-A binding could functionally affect IgG-mediated phagocytosis of C. neoformans by alveolar macrophages in vitro. For these experiments C. neoformans cells were fluorescently labeled with AF-647, which had no affect on C. neoformans uptake by alveolar macrophages in preliminary experiments (results not shown). Attachment/phagocytosis was quantified by flow cytometry. Non-IgG opsonized C. neoformans were attached/phagocytosed by less than 1% of the alveolar macrophage population in the presence or absence of SP-A, thus percent inhibition of uptake for these conditions is presented as approximately100% (Figure 3). We observed that all the SP-A concentrations tested (20, 40 and 80 microg/ml) significantly (P<0.001) inhibited the uptake of anti-GXM IgG opsonized C. neoformans yeast by alveolar macrophages and that this inhibition occurred in a dose dependent manner (16+/-3.1%, 34+/-2.7% and 46+/-3.0%, respectively) (Figure 3). These results demonstrate a unique mechanism by which SP-A inhibits, rather than enhances, the phagocytosis of an antibody opsonized microorganism by alveolar macrophages.
###end p 29
###begin title 30
###xml 42 55 42 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 42 55 <span type="species:ncbi:5207">C. neoformans</span>
SP-A inhibits the uptake of IgG opsonized C. neoformans by alveolar macrophages.
###end title 30
###begin p 31
###xml 18 31 18 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 285 286 269 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 332 345 316 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 351 352 335 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 383 384 367 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 18 31 <span type="species:ncbi:5207">C. neoformans</span>
###xml 332 345 <span type="species:ncbi:5207">C. neoformans</span>
Non-IgG opsonized C. neoformans were attached/phagocytosed by less than 1% of the alveolar macrophage population in the presence or absence of SP-A, thus percent inhibition of uptake for these conditions is presented as approximately100%. SP-A (20, 40 and 80 microg/ml) significantly (P<0.001) inhibited the uptake of IgG opsonized C. neoformans (1x105) by alveolar macrophages (1x105) in a dose dependent manner (16+/-3.1%, 34+/-2.7% and 46+/-3.0%, respectively). Results represent the mean plus or minus the standard error of the mean of three experiments.
###end p 31
###begin title 32
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SP-A-/-</italic>
###xml 49 62 49 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 49 62 <span type="species:ncbi:5207">C. neoformans</span>
SP-A-/- mice exhibit wild-type susceptibility to C. neoformans
###end title 32
###begin p 33
###xml 4 12 4 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 126 139 126 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 279 300 279 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans in vivo</italic>
###xml 580 593 580 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 671 678 671 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SP-A-/-</italic>
###xml 691 698 691 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SP-A-/-</italic>
###xml 764 777 764 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 789 790 789 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 126 139 <span type="species:ncbi:5207">C. neoformans</span>
###xml 279 292 <span type="species:ncbi:5207">C. neoformans</span>
###xml 580 593 <span type="species:ncbi:5207">C. neoformans</span>
###xml 602 608 <span type="species:ncbi:10090">murine</span>
###xml 657 662 <span type="species:ncbi:10090">mouse</span>
###xml 713 717 <span type="species:ncbi:10090">mice</span>
###xml 764 777 <span type="species:ncbi:5207">C. neoformans</span>
Our in vitro studies suggested that the classic role of SP-A as an opsonin was unlikely to contribute to host defense against C. neoformans. In fact, its affect on IgG-mediated phagocytosis could enhance extracellular colonization and thus change the growth and dissemination of C. neoformans in vivo. Furthermore, SP-A is also known to contribute to host defense via other mechanisms, such as modulation of the immune response. Therefore, we could not predict the impact of SP-A on cryptococcosis. We explored the role of SP-A as a modulator of the early immune response against C. neoformans using a murine pulmonary infection model and an SP-A deficient mouse strain (SP-A-/-). Groups of SP-A-/- and wild-type mice were infected via intranasal inoculation with C. neoformans cells (1x104) and several defined endpoints were analyzed at days three and seven post infection.
###end p 33
###begin p 34
###xml 98 111 98 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 178 185 178 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SP-A-/-</italic>
###xml 387 400 387 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 402 411 402 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001370-g004">Figure 4A</xref>
###xml 467 468 467 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 596 605 596 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001370-g004">Figure 4B</xref>
###xml 624 637 624 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 98 111 <span type="species:ncbi:5207">C. neoformans</span>
###xml 264 268 <span type="species:ncbi:10090">mice</span>
###xml 387 400 <span type="species:ncbi:5207">C. neoformans</span>
###xml 486 491 <span type="species:ncbi:4932">yeast</span>
###xml 532 537 <span type="species:ncbi:10090">mouse</span>
###xml 624 637 <span type="species:ncbi:5207">C. neoformans</span>
We began by first investigating whether SP-A deficiency affected the colonization of the lungs by C. neoformans. Bronchoalveolar lavage fluid and lung tissue were collected from SP-A-/- (n = 3 and n = 8, respectively) and wild-type (n = 4 and n = 7, respectively) mice at days three and seven post infection. We found that SP-A deficiency did not affect the colonization of the lungs by C. neoformans (Figure 4A). At day seven post infection a significantly greater (P<0.001) number of yeast were present in the lung tissue of both mouse strains, as compared to the bronchoalveolar lavage fluid (Figure 4B), suggesting that C. neoformans had equally invaded the pulmonary parenchyma of both strains.
###end p 34
###begin title 35
###xml 0 13 0 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 60 67 60 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SP-A-/-</italic>
###xml 0 13 <span type="species:ncbi:5207">C. neoformans</span>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
C. neoformans infection appears to progress equivalently in SP-A-/- and wild-type mice.
###end title 35
###begin p 36
###xml 125 132 125 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SP-A-/-</italic>
###xml 477 484 477 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SP-A-/-</italic>
###xml 596 603 596 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SP-A-/-</italic>
###xml 661 674 661 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 742 749 738 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SP-A-/-</italic>
###xml 876 877 872 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 165 169 <span type="species:ncbi:10090">mice</span>
###xml 493 497 <span type="species:ncbi:10090">mice</span>
###xml 626 630 <span type="species:ncbi:10090">mice</span>
###xml 661 674 <span type="species:ncbi:5207">C. neoformans</span>
###xml 750 754 <span type="species:ncbi:10090">mice</span>
(A.) Three days post infection the fungal burdens of lung tissue and BALs from wild-type (n = 4 and n = 7, respectively) and SP-A-/- (n = 3 and n = 8, respectively) mice were equivalent. (B.) A similar trend was observed at day seven post infection; no difference between groups were observed. (C.) Quantitative differentials showed no differences in the numbers of macrophages, polymorphonuclear neutrophils or lymphocytes present in BALs collected from wild-type (n = 3) and SP-A-/- (n = 3) mice seven days post infection. (D.) There were also no differences in the numbers of macrophages from SP-A-/- (n = 3) and wild-type mice (n = 3) that had phagocytosed C. neoformans. TNFalpha levels (measured by ELISA) in the lungs of wild-type and SP-A-/- mice at day three (n = 8 and n = 7, respectively) and seven (n = 16 and n = 17, respectively) post infection were equivalent (P>0.05). Results represent the mean plus or minus the standard error of the mean for the indicated number of experiments. (AM, alveolar macrophage; PMN, polymorphonuclear neutrophils; Lymphs, lymphocytes; BAL, bronchoalveolar fluid)
###end p 36
###begin p 37
###xml 282 289 282 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SP-A-/-</italic>
###xml 374 383 374 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001370-g004">Figure 4C</xref>
###xml 493 506 493 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 537 538 537 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 580 593 580 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 642 649 642 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SP-A-/-</italic>
###xml 711 720 711 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001370-g004">Figure 4D</xref>
###xml 786 799 786 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 912 919 904 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SP-A-/-</italic>
###xml 1073 1089 1065 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001370-g004">Figure 4E and 4F</xref>
###xml 1210 1223 1198 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 137 143 <span type="species:ncbi:10090">murine</span>
###xml 320 324 <span type="species:ncbi:10090">mice</span>
###xml 493 506 <span type="species:ncbi:5207">C. neoformans</span>
###xml 580 593 <span type="species:ncbi:5207">C. neoformans</span>
###xml 692 696 <span type="species:ncbi:10090">mice</span>
###xml 786 799 <span type="species:ncbi:5207">C. neoformans</span>
###xml 934 938 <span type="species:ncbi:10090">mice</span>
###xml 1210 1223 <span type="species:ncbi:5207">C. neoformans</span>
We then investigated whether SP-A deficiency affected the recruitment of immune cells to the lungs in response to this infection in both murine strains. We found that the numbers of alveolar macrophages, polymorphonuclear cells or lymphocytes in the bronchoalveolar lavage fluid of SP-A-/- (n = 3) and wild-type (n = 3) mice at day seven day post infection were equivalent (Figure 4C), suggesting that SP-A deficiency did not affect the recruitment of immune cells in response to infection by C. neoformans. Furthermore, no significant (P>0.05) differences between the numbers of C. neoformans cells phagocytosed by alveolar macrophages from SP-A-/- (n = 3), as compared to wild-type (n = 3) mice was observed (Figure 4D). To investigate the impact on cytokine response to infection by C. neoformans, we measured a major Th1 cytokine, TNFalpha. We found that TNFalpha levels in bronchoalveolar lavage fluid from SP-A-/- and wild-type mice did not differ significantly at day three (n = 8 and n = 7, respectively) and seven (n = 16 and n = 17, respectively) post infection (Figure 4E and 4F). These results support the concept that SP-A deficiency did not affect TNFalpha production in response to infection by C. neoformans.
###end p 37
###begin p 38
###xml 63 70 63 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SP-A-/-</italic>
###xml 135 148 135 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 160 161 160 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 343 344 343 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 405 413 405 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001370-g005">Figure 5</xref>
###xml 530 543 530 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
###xml 135 148 <span type="species:ncbi:5207">C. neoformans</span>
###xml 149 154 <span type="species:ncbi:4932">yeast</span>
###xml 270 274 <span type="species:ncbi:10090">mice</span>
###xml 509 513 <span type="species:ncbi:10090">mice</span>
###xml 530 543 <span type="species:ncbi:5207">C. neoformans</span>
As a final comparison of SP-A impact on infection, groups of 5 SP-A-/- and wild-type mice were infected by intranasal inoculation with C. neoformans yeast (1x105) to investigate whether SP-A deficiency affected the final outcome of infection. By day 32 of infection all mice had succumbed to infection and died with no significant difference (P>0.05) in the mean time of mortality between the two groups (Figure 5). These results support the concept that SP-A deficiency does not affect the susceptibility of mice to infection by C. neoformans.
###end p 38
###begin title 39
###xml 64 78 64 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans.</italic>
###xml 64 77 <span type="species:ncbi:5207">C. neoformans</span>
SP-A deficiency does not enhance susceptibility to infection by C. neoformans.
###end title 39
###begin p 40
###xml 12 19 12 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SP-A-/-</italic>
###xml 58 71 58 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 82 83 82 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 217 224 217 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SP-A-/-</italic>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
###xml 58 71 <span type="species:ncbi:5207">C. neoformans</span>
###xml 73 76 <span type="species:ncbi:5207">H99</span>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 247 251 <span type="species:ncbi:10090">mice</span>
Groups of 5 SP-A-/- and wild-type mice were infected with C. neoformans (H99, 1x105) via intranasal inhalation. All mice succumbed to infection and died by day 32. There was no difference in the mean time to death of SP-A-/- and wild-type C57BL/6 mice.
###end p 40
###begin title 41
Discussion
###end title 41
###begin p 42
###xml 54 67 54 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 155 168 155 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 294 315 294 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aspergillus fumigatus</italic>
###xml 315 318 315 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Madan1">[5]</xref>
###xml 320 341 320 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pneumocystis jiroveci</italic>
###xml 341 345 341 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Zimmerman1">[17]</xref>
###xml 347 369 347 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Coccidioides posadasii</italic>
###xml 369 373 369 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Awasthi1">[18]</xref>
###xml 379 401 379 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Histoplasma capsulatum</italic>
###xml 401 405 401 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-McCormack2">[19]</xref>
###xml 508 533 508 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae.</italic>
###xml 631 644 631 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. cerevisiae</italic>
###xml 678 682 678 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Allen1">[20]</xref>
###xml 684 688 684 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Haurum1">[21]</xref>
###xml 752 765 752 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. cerevisiae</italic>
###xml 826 830 826 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Haurum1">[21]</xref>
###xml 875 888 875 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 944 948 940 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Cruickshank1">[22]</xref>
###xml 950 954 946 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Granger1">[23]</xref>
###xml 989 993 985 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Nosanchuk1">[24]</xref>
###xml 1046 1059 1042 1055 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 1138 1146 1134 1142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1307 1311 1299 1303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Walenkamp1">[11]</xref>
###xml 54 67 <span type="species:ncbi:5207">C. neoformans</span>
###xml 155 168 <span type="species:ncbi:5207">C. neoformans</span>
###xml 294 315 <span type="species:ncbi:5085">Aspergillus fumigatus</span>
###xml 320 341 <span type="species:ncbi:42068">Pneumocystis jiroveci</span>
###xml 347 369 <span type="species:ncbi:199306">Coccidioides posadasii</span>
###xml 379 401 <span type="species:ncbi:5037">Histoplasma capsulatum</span>
###xml 502 507 <span type="species:ncbi:4932">yeast</span>
###xml 508 532 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 631 644 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 672 677 <span type="species:ncbi:4932">yeast</span>
###xml 752 765 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 875 888 <span type="species:ncbi:5207">C. neoformans</span>
###xml 889 894 <span type="species:ncbi:4932">yeast</span>
###xml 1046 1059 <span type="species:ncbi:5207">C. neoformans</span>
The inability of SP-A to bind encapsulated strains of C. neoformans is surprising given that SP-A binds a diverse assortment of carbohydrates and that the C. neoformans capsule and cell wall possess abundant and varied carbohydrates. Indeed, SP-A binds well to other pathogenic fungi including Aspergillus fumigatus[5], Pneumocystis jiroveci[17], Coccidioides posadasii[18], and Histoplasma capsulatum[19]. One explanation of these results may be found in studies that investigated SP-A binding to the yeast Saccharomyces cerevisiae. These studies found that despite the presence of accessible carbohydrates on the cell surface of S. cerevisiae SP-A does not bind to this yeast [20], [21]. This was hypothesized to be due to charge repulsion; SP-A and S. cerevisiae cell wall mannan both carry a net negative charge at pH 7.4 [21]. The capsular polysaccharide that surrounds C. neoformans yeast, which can reach diameters as large as 80 microm [22], [23] is very highly negatively charged [24]. It is possible that the absence of SP-A binding to C. neoformans is also due to charge repulsion. Since the concentrations of SP-A used in our in vitro binding assays were comparable or even higher than those thought to exist in the lungs of healthy individuals under physiological conditions (1 to 2 microg/ml) [11], it is unlikely that the binding deficiency was simply due to limited availability of SP-A.
###end p 42
###begin p 43
###xml 192 205 192 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 588 601 588 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 838 851 834 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 851 854 847 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Mitchell1">[1]</xref>
###xml 956 960 952 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Lin1">[25]</xref>
###xml 1104 1111 1100 1107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 192 205 <span type="species:ncbi:5207">C. neoformans</span>
###xml 588 601 <span type="species:ncbi:5207">C. neoformans</span>
###xml 602 607 <span type="species:ncbi:4932">yeast</span>
###xml 838 851 <span type="species:ncbi:5207">C. neoformans</span>
This is the first report that has demonstrated IgG dependent binding of SP-A to a microorganism. Several lines of evidence suggest that this occurs via a mechanism in which IgG first binds to C. neoformans capsule and then SP-A binds to bound IgG. First, we showed that SP-A binding was not inhibited by EDTA, demonstrating that the SP-A carbohydrate recognition domain was not required. This ruled out the possibility of SP-A binding to carbohydrate ligands that may have been exposed as a result of anti-GXM IgG binding. Second, SP-A binding inhibited the IgG dependent phagocytosis of C. neoformans yeast by alveolar macrophages. This observation suggested that SP-A binding functionally interfered with IgG binging to the Fcgamma receptor on the cell surface of alveolar macrophages, which is required for phagocytosis in the case of C. neoformans[1]. Third, a recent study in our laboratory showed that SP-A can bind directly to the Fc portion of IgG [25]. Since SP-A was used at physiologically relevant concentrations for these studies, our results suggest that this interaction could occur under in vivo conditions.
###end p 43
###begin p 44
###xml 153 174 153 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aspergillus fumigatus</italic>
###xml 223 226 223 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Madan1">[5]</xref>
###xml 324 328 324 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Kishor1">[26]</xref>
###xml 343 350 343 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SP-A-/-</italic>
###xml 440 451 440 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. jiroveci</italic>
###xml 451 455 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Atochina1">[27]</xref>
###xml 460 473 460 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. capsulatum</italic>
###xml 473 477 473 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-McCormack2">[19]</xref>
###xml 513 526 513 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 559 566 559 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 648 655 648 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SP-A-/-</italic>
###xml 153 174 <span type="species:ncbi:5085">Aspergillus fumigatus</span>
###xml 267 271 <span type="species:ncbi:10090">mice</span>
###xml 351 355 <span type="species:ncbi:10090">mice</span>
###xml 440 451 <span type="species:ncbi:42068">P. jiroveci</span>
###xml 460 473 <span type="species:ncbi:5037">H. capsulatum</span>
###xml 513 526 <span type="species:ncbi:5207">C. neoformans</span>
###xml 670 674 <span type="species:ncbi:10090">mice</span>
SP-A mediated mechanisms of host defense provide protection against several pathogenic fungi. For example, SP-A enhances the phagocytosis and killing of Aspergillus fumigatus conidia by alveolar macrophages and neutrophils [5]. In addition, administration of SP-A to mice with invasive aspergillosis rescued them from death [26]. Studies with SP-A-/- mice have shown that SP-A deficiency results in increased susceptibility to infection by P. jiroveci[27] and H. capsulatum[19]. However, this is not the case for C. neoformans. The end points analyzed in our in vivo studies clearly demonstrated an equivalent progression and outcome of disease in SP-A-/- and wild-type mice.
###end p 44
###begin p 45
###xml 236 240 236 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Crowther1">[28]</xref>
###xml 272 279 272 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SP-A-/-</italic>
###xml 497 510 497 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 543 556 543 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 610 614 610 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Giles1">[13]</xref>
###xml 615 619 615 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001370-Giles3">[15]</xref>
###xml 760 768 760 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 773 780 773 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 894 907 894 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. neoformans</italic>
###xml 280 284 <span type="species:ncbi:10090">mice</span>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
###xml 497 510 <span type="species:ncbi:5207">C. neoformans</span>
###xml 543 556 <span type="species:ncbi:5207">C. neoformans</span>
###xml 673 678 <span type="species:ncbi:4932">yeast</span>
###xml 888 893 <span type="species:ncbi:4932">yeast</span>
###xml 894 907 <span type="species:ncbi:5207">C. neoformans</span>
###xml 996 1002 <span type="species:ncbi:10090">murine</span>
Another mechanism by which SP-A can mediate host defense is via direct modulation of alveolar macrophage function. SP-A can reduce reactive oxygen intermediate production by alveolar macrophages via the down regulation of NADPH oxidase [28]. Thus, alveolar macrophages in SP-A-/- mice would be expected to produce increased levels of reactive oxygen species as compared to wild-type mice. This up regulation of reactive oxygen species however would not be expected to have a significant effect on C. neoformans colonization of the lungs since C. neoformans possesses a highly robust antioxidant defense system [13]-[15] and the absence or presence of SP-A had no impact on yeast growth, host immune cell recruitment or cytokine production. Taken together, the in vitro and in vivo results of this study suggest that unlike a variety of bacteria, viruses and other fungi, the encapsulated yeast C. neoformans does not appear to be susceptible to SP-A mediated mechanisms of innate immunity in the murine pulmonary tract.
###end p 45
###begin p 46
We are grateful to Dr. Amy Pastva and Dr. Taylor Dagenais for comments and critical reading of the manuscript. The authors also wish to thank Dr. John F. Whitesides for assistance with flow cytometry and Dr. Delphine Malherbe for assistance with fluorescence labeling of SP-A and helpful discussions.
###end p 46
###begin title 47
References
###end title 47
###begin article-title 48
###xml 67 90 67 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cryptococcus neoformans</italic>
###xml 67 79 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 67 90 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans.
###end article-title 48
###begin article-title 49
Surfactant protein A stimulates phagocytosis of specific pulmonary pathogens by alveolar macrophages.
###end article-title 49
###begin article-title 50
###xml 57 84 <span type="species:ncbi:12814">respiratory syncytial virus</span>
Surfactant protein A binds to the fusion glycoprotein of respiratory syncytial virus and neutralizes virion infectivity.
###end article-title 50
###begin article-title 51
Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins.
###end article-title 51
###begin article-title 52
###xml 52 73 52 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aspergillus fumigatus</italic>
###xml 52 73 <span type="species:ncbi:5085">Aspergillus fumigatus</span>
###xml 119 124 <span type="species:ncbi:9606">human</span>
Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages.
###end article-title 52
###begin article-title 53
###xml 114 134 114 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pneumocystis carinii</italic>
###xml 114 134 <span type="species:ncbi:4754">Pneumocystis carinii</span>
The carbohydrate recognition domain of surfactant protein A mediates binding to the major surface glycoprotein of Pneumocystis carinii.
###end article-title 53
###begin article-title 54
Surfactant proteins A and D and pulmonary host defense.
###end article-title 54
###begin article-title 55
Immunomodulatory functions of surfactant.
###end article-title 55
###begin article-title 56
Immunoregulatory functions of surfactant proteins.
###end article-title 56
###begin article-title 57
###xml 51 74 51 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cryptococcus neoformans</italic>
###xml 45 50 <span type="species:ncbi:4932">yeast</span>
###xml 51 63 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 51 74 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
###xml 76 81 <span type="species:ncbi:9606">human</span>
###xml 139 144 <span type="species:ncbi:4932">yeast</span>
Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells.
###end article-title 57
###begin article-title 58
###xml 40 63 40 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cryptococcus neoformans</italic>
###xml 40 52 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 40 63 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
Pulmonary surfactant protein A binds to Cryptococcus neoformans without promoting phagocytosis.
###end article-title 58
###begin article-title 59
Surfactant protein A inhibits alveolar macrophage cytokine production by CD14-independent pathway.
###end article-title 59
###begin article-title 60
###xml 0 23 0 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cryptococcus neoformans</italic>
###xml 0 12 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 0 23 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
Cryptococcus neoformans mitochondrial superoxide dismutase: an essential link between antioxidant function and high-temperature growth.
###end article-title 60
###begin article-title 61
###xml 66 89 66 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cryptococcus neoformans</italic>
###xml 66 78 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 66 89 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
Cytochrome c peroxidase contributes to the antioxidant defense of Cryptococcus neoformans.
###end article-title 61
###begin article-title 62
###xml 4 27 4 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cryptococcus neoformans</italic>
###xml 4 16 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 4 27 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
The Cryptococcus neoformans Catalase Gene Family and Its Role in Antioxidant Defense.
###end article-title 62
###begin article-title 63
###xml 95 118 95 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cryptococcus neoformans</italic>
###xml 95 107 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 95 118 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
Monoclonal antibodies can affect complement deposition on the capsule of the pathogenic fungus Cryptococcus neoformans by both classical pathway activation and steric hindrance.
###end article-title 63
###begin article-title 64
###xml 31 51 31 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pneumocystis carinii</italic>
###xml 31 51 <span type="species:ncbi:4754">Pneumocystis carinii</span>
120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A.
###end article-title 64
###begin article-title 65
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Coccidioides posadasii</italic>
###xml 0 22 <span type="species:ncbi:199306">Coccidioides posadasii</span>
Coccidioides posadasii infection alters the expression of pulmonary surfactant proteins (SP)-A and SP-D.
###end article-title 65
###begin article-title 66
Macrophage-independent fungicidal action of the pulmonary collectins.
###end article-title 66
###begin article-title 67
###xml 49 73 49 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 78 99 78 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aspergillus fumigatus</italic>
###xml 49 73 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 78 99 <span type="species:ncbi:5085">Aspergillus fumigatus</span>
Interactions of surfactant proteins A and D with Saccharomyces cerevisiae and Aspergillus fumigatus.
###end article-title 67
###begin article-title 68
###xml 55 60 <span type="species:ncbi:9606">human</span>
Studies on the carbohydrate-binding characteristics of human pulmonary surfactant-associated protein A and comparison with two other collectins: mannan-binding protein and conglutinin.
###end article-title 68
###begin article-title 69
###xml 0 23 0 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cryptococcus neoformans</italic>
###xml 0 12 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 0 23 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
Cryptococcus neoformans of unusual morphology.
###end article-title 69
###begin article-title 70
###xml 13 36 13 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cryptococcus neoformans</italic>
###xml 13 25 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 13 36 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide.
###end article-title 70
###begin article-title 71
###xml 19 42 19 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cryptococcus neoformans</italic>
###xml 19 31 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 19 42 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
Cellular charge of Cryptococcus neoformans: contributions from the capsular polysaccharide, melanin, and monoclonal antibody binding.
###end article-title 71
###begin article-title 72
Surfactant protein A binds to IgG and enhances phagocytosis of IgG-opsonized erythrocytes.
###end article-title 72
###begin article-title 73
###xml 111 132 111 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aspergillus fumigatus</italic>
###xml 111 132 <span type="species:ncbi:5085">Aspergillus fumigatus</span>
Protective roles of pulmonary surfactant proteins, SP-A and SP-D, against lung allergy and infection caused by Aspergillus fumigatus.
###end article-title 73
###begin article-title 74
###xml 46 66 46 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pneumocystis carinii</italic>
###xml 46 66 <span type="species:ncbi:4754">Pneumocystis carinii</span>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
Enhanced lung injury and delayed clearance of Pneumocystis carinii in surfactant protein A-deficient mice: attenuation of cytokine responses and reactive oxygen-nitrogen species.
###end article-title 74
###begin article-title 75
Pulmonary surfactant protein A inhibits macrophage reactive oxygen intermediate production in response to stimuli by reducing NADPH oxidase activity.
###end article-title 75
###begin p 76
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 76
###begin p 77
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
###xml 186 191 <span type="species:ncbi:9606">Human</span>
Funding: This work was supported by grants from the National Institutes of Health (HL-51134 and HL-30923). SSG was supported by a National Institutes of Health RSUM (HL-51134). The Duke Human Vaccine Institute Flow Cytometry Core Facility is supported by a National Institutes of Health grant (AI-051445). These funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.
###end p 77

